FindTrial
Sign In

Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

Therapeutic Potential of Kappa-Opioids Against Cocaine

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00000323
Enrollment
10
Registered
1999-09-21
Start date
1996-07-31
Completion date
1998-12-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Interventions

None listed

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

opiate experienced, healthy

Exclusion criteria

physical dependence on opioids, barbiturates or alcohol

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026